Skip to Content

  • Search

View Additional Section Content

RTOG 0627 - Phase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiforme. Closed to accrual 10/19/07. (To determine response before proceeding to 2nd stage of accrual)

Clinical Trial Categories

  • Brain Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details